Lv21
130 积分 2022-08-02 加入
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
5小时前
已完结
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
5个月前
已完结
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
5个月前
已完结
Angiogenesis and Pancreatic Cancer: Novel Approaches to Overcome Treatment Resistance
9个月前
已完结
Cancer statistics, 2024
9个月前
已完结
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial
10个月前
已完结
Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database
1年前
已完结
Brain metastasis in breast cancer: a comprehensive literature review
1年前
已完结
Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial
1年前
已完结
皖公网安备34019202002308
